Biomarkers in schizophrenia

Schizophrenia is one of the most complex and serious psychiatric disorders. Despite decades of research, many of its causes remain unexplained. In recent years, interest in biomarkers has grown considerably, as they offer the possibility of putting diagnosis, prognosis and therapy on a more objective and personalized basis. Genetic, neurobiological, developmental and epigenetic factors play a central role here. This article summarizes the current state of research and shows perspectives on how biomarkers could revolutionize the clinical care of patients with schizophrenia in the future.